Healthcare

Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments such as GLP-1 Receptor Agonists | DelveInsight

LAS VEGAS, Nov. 20, 2025, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Radiology AI Market worth $2.27 billion by 2030 with 24.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 20, 2025, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

NASH/MASH Treatment Market to Surpass USD 31.76 Billion by 2033 as First-in-Class Drugs Redefine Fatty Liver Disease Management | According to DataM Intelligence

AUSTIN, Texas and TOKYO, Nov. 20, 2025, 06:30 GMT-05

DataM-Intelligence

Read full article →

KLKB1 Inhibitors Market to Reach New Heights by 2034 Owing to the Launch of Novel Therapies | DelveInsight

LAS VEGAS, Nov. 19, 2025, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Multilayer Co-extruded Film Market Size to Reach USD 3.64 Billion by 2031, Growing at 5.5% CAGR | Valuates Reports

BANGALORE, India, Nov. 19, 2025, 11:49 GMT-05

Valuates-Reports

Read full article →

Vascular Imaging Market worth US$4.54 billion by 2030 with 7.3% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 19, 2025, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run and $9.8 Billion by 2034 Globally, at 6.4% CAGR: Allied Market Research

PORTLAND, Ore., Nov. 19, 2025, 10:16 GMT-05

Allied-Market

Read full article →

Cell Culture Media Market Outlook: Strong 13.2% CAGR to Drive $12.8 Billion Revenue by 2033 - Grand View Research, Inc.

SAN FRANCISCO, Nov. 19, 2025, 10:10 GMT-05

GRAND-VIEW-RESEARCH

Read full article →

Hepatitis B and C Therapeutics Market Surges to US$17.02 Billion in 2024 as Innovation, National Screening Policies, and Next-Gen Antivirals Transform Global Care | According to DataM Intelligence

AUSTIN, Texas and TOKYO, Nov. 19, 2025, 10:01 GMT-05

DataM-Intelligence

Read full article →

New Survey Reveals Ongoing Communication Barriers for Deaf and Hard-of-Hearing in Social, Medical, and Professional Settings

NEW YORK, Nov. 19, 2025, 09:00 GMT-05

Nagish-Research

Read full article →

Thin-Film Electrode Market worth $0.97 billion by 2030 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 19, 2025, 06:59 GMT-05

MarketsandMarkets

Read full article →

European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe

BRUSSELS, Nov. 19, 2025, 03:00 GMT-05

Viatris-AMR-Findings

Read full article →

New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management

OSLO, Norway, Nov. 19, 2025, 02:34 GMT-05

Photocure-ASA

Read full article →

TruDoc Launches Intelligent, Next-Generation Super Health App

DUBAI, UAE, Nov. 19, 2025, 02:00 GMT-05

Trudoc-Health

Read full article →

Nextcare and MEDGULF Announce Strategic Partnership to Strengthen Healthcare Administration in the Region

BEIRUT, Nov. 19, 2025, 01:00 GMT-05

Nextcare-MEDGULF

Read full article →

Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving Intramuscular TXA Injection for Prehospital Care

JERUSALEM, Nov. 19, 2025, 00:01 GMT-05

Rafa-Labs-BARDA

Read full article →

Wearable Medical Devices Market Will reach $184.75 billion by 2033 - Strategic Revenue Insights

LONDON, Nov. 19, 2025, 23:41 GMT-05

STRATEGIC-REVENUE

Read full article →

Osteoporosis Market Set to Expand Significantly During the Forecast Period (2025-2034) Due to Rising Aging Population and Novel Therapeutics | DelveInsight

LAS VEGAS, Nov. 18, 2025, 17:31 GMT-05

DelveInsight-Business

Read full article →

Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

DUBLIN, Nov. 18, 2025, 16:15 GMT-05

JazzPharma-HealthConf

Read full article →

European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

BRIDGEWATER, N.J., Nov. 18, 2025, 11:06 GMT-05

Insmed-BRINSUPRI

Read full article →